Kiora Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€0.69
Target price
31.12.25
€1.00
Performance (%)
-37.75%
End price
14.12.24
-
Summary
This prediction is currently being closed. The BUY prediction by BiotechBee for Kiora Pharmaceuticals Inc. is performing very badly with a performance of -37.75%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kiora Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
According to BiotechBee what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year